🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Diabetes Mellitus, Type 1 Diabetes

The iLet Experience Study NCT06891898n/a1 site📍 Irvine Beta Bionics, Inc. · Tests: iLet Dosing Decision Software Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus NCT06964087Phase 25 sites📍 Birmingham📍 Walnut Creek📍 Aurora Op-T LLC · Tests: OPT101, OPT101 Placebo to Match (PTM) Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes NCT07828106NA1 site📍 Ramat Gan Sheba Medical Center · Tests: Tele-diabetes Remote System Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes NCT05498116Phase 41 site📍 Aurora University of Colorado, Denver · Tests: Montelukast, Placebo Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes NCT07599982NA6 sites📍 Baltimore📍 Detroit📍 Albany DreaMed Diabetes · Tests: MODI Algorithm Intervention for Children With Type 1 Diabetes Targeting Gut Microbes NCT06198725NA1 site📍 Shanghai Children's Hospital of Fudan University · Tests: Trimtab An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant NCT06832410Phase 37 sites📍 Philadelphia📍 Pittsburgh📍 Madison Vertex Pharmaceuticals Incorporated · Tests: Biological/Vaccine AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy NCT06494995Phase 21 site📍 Shanghai Fudan University · Tests: Cadonilimab, Low-dose radiotherapy, SBRT, Capecitabine Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity. NCT07891156Phase 2, Phase 31 site📍 Montreal McGill University Health Centre/Research Institute of the M… · Tests: Semaglutide, Placebo Satisfaction of Specific Modes Related to Physical Activity in People Living With Type 1 Diabetes and Using an Hybrid Closed-loop System NCT07567170NA1 site📍 Grenoble University Hospital, Grenoble · Tests: Questionnar Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes NCT07667504NA1 site📍 Málaga Fundación Pública Andaluza para la Investigación de Málaga … · Tests: Moderate carbohydrate restriction, Early time-restricted eating, Standard calorie restriction Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes NCT07167693Phase 1, Phase 21 site📍 Detroit David K Carroll · Tests: Arginine hydrochloride, Sodium Chloride 0.9% Registry of Patients Living With Type 1 Diabetes NCT03720197n/a7 sites📍 Edmonton📍 Montreal📍 Montreal Institut de Recherches Cliniques de Montreal · Tests: Online questionnaire - Phase 1, Online questionnaire - Phase 2, Online questionnaire - Phase 3, Food questionnaire, Ped… CGM Academy for Youth With Type 1 Diabetes NCT06408207NA1 site📍 Los Angeles Children's Hospital Los Angeles · Tests: CGM Academy Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes NCT07240012NA8 sites📍 Aalborg📍 Aarhus📍 Aarhus Copenhagen University Hospital, Rigshospitalet · Tests: Automated closed-loop insulin delivery Type 1 Diabetes, Exercise and Mentoring Trial NCT06296992NA2 sites📍 Winnipeg📍 Mississauga University of Manitoba · Tests: 12-week TEAM peer mentor program Immune Function and the Progression to T1D NCT05899439n/a3 sites📍 Gainesville📍 Columbus📍 Houston University of Florida · Tests: blood draw Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) NCT07227805NA9 sites📍 Antwerp📍 Brussels📍 Leuven Medtronic MiniMed, Inc. · Tests: NMX8, 780G Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes NCT06618027NA2 sites📍 Aurora📍 Washington D.C. Children's National Research Institute · Tests: BREATHE-T1D, HealthEd-T1D Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss NCT01999361NA1 site📍 Miami Rodolfo Alejandro · Tests: Myfortic Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy. NCT07611721NA1 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: Continuous glucose monitor Impact of the Menstrual Cycle in Reproductive Aged Women With Type 1 Diabetes Using a Closed Loop System (DIABETEXX/1). NCT06338072n/a1 site📍 Madrid Fundacion para la Investigacion Biomedica del Hospital Univ… Family Intervention for Black Teens With Type 1 Diabetes NCT06275412NA4 sites📍 Washington D.C.📍 Detroit📍 Memphis Wayne State University · Tests: The 3Ms 2.0 Intervention, Educational Attention Control (EAC) The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients NCT05938712Phase 21 site📍 Toronto University Health Network, Toronto · Tests: Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes NCT06820281Phase 21 site📍 Sydney Victor Chang Cardiac Research Institute · Tests: Tirzepatide 2.5mg weekly, Placebo injection (normal saline) GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes NCT06630585Phase 33 sites📍 Chêne-Bougeries📍 Olten📍 Lucerne University of Bern · Tests: Tirzepatide Commercial or Open Source Closed Loop Impact on Pregnancy Study NCT06654713n/a1 site📍 San Francisco University of California, San Francisco · Tests: Commercial AID system, Open source AID system Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) NCT06564623Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: mBTC vax [0.3 - 2.4 mg peptide + 0.5 mg Poly-ICLC (Hiltonol)], Durvalumab, Tremelimumab Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes NCT06297980NA1 site📍 Aurora University of Colorado, Denver · Tests: Personalized modifications to treatment to address menstrual cycle effects on glycemia
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy